Irish ministry listens to industry overture to unblock pricing impasse
This article was originally published in Scrip
Executive Summary
Ireland's minister for health Dr James Reilly has signalled to the pharmaceutical industry that he is willing to open negotiations regarding patient access to new medicines that are awaiting funding under the state drug schemes. The Irish Pharmaceutical Healthcare Association (IPHA) is offering to cut the price of newly launched generic medicines by 30% in return for a new agreement ensuring the reimbursement of new medicines.